Carregant...

Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice

Recent clinical trials have demonstrated that combination therapy with renin-angiotensin system inhibitors plus calcium channel blockers (CCBs) elicits beneficial effects on cardiovascular and renal events in hypertensive patients with high cardiovascular risks. In the present study, we hypothesized...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rafiq, Kazi, Sherajee, Shamshad J., Hitomi, Hirofumi, Nakano, Daisuke, Kobori, Hiroyuki, Ohmori, Koji, Mori, Hirohito, Kobara, Hideki, Masaki, Tsutomu, Kohno, Masakazu, Nishiyama, Akira
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3858271/
https://ncbi.nlm.nih.gov/pubmed/24339994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0082082
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!